Leonard L. Mazur, Executive Chairman, 10% Owner at Citius Pharmaceuticals, Inc. (CTXR), bought 11,000 shares at $2.68 ($29K) on 2017-08-24, disclosed to the SEC on 2017-08-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| CTXR | BUY | 2019-04-05 | $3.6M | — | Filing → |
| CTXR | BUY | 2018-08-15 | $8.0M | — | Filing → |
| CTXR | BUY | 2018-04-02 | $1.0M | — | Filing → |